Bio MedPoint's predictive tool uses gel capillary electrophoresis to determine risk of Coronary Artery Disease. From a simple blood test, we can detect a patient's protein fingerprint at 94% accuracy in one hour. We will run these tests in a CLIA-certified lab and provide test results back to patients. Once we are certified, we can then run clinical trials to sell our predictive tool as a medical device to labs and doctor offices nationally.